TAF13

Chr 1AR

TATA-box binding protein associated factor 13

Also known as: MRT60, TAF(II)18, TAF2K, TAFII-18, TAFII18

Initiation of transcription by RNA polymerase II requires the activities of more than 70 polypeptides. The protein that coordinates these activities is transcription factor IID (TFIID), which binds to the core promoter to position the polymerase properly, serves as the scaffold for assembly of the remainder of the transcription complex, and acts as a channel for regulatory signals. TFIID is composed of the TATA-binding protein (TBP) and a group of evolutionarily conserved proteins known as TBP-associated factors or TAFs. TAFs may participate in basal transcription, serve as coactivators, function in promoter recognition or modify general transcription factors (GTFs) to facilitate complex assembly and transcription initiation. This gene encodes a small subunit associated with a subset of TFIID complexes. This subunit interacts with TBP and with two other small subunits of TFIID, TAF10 and TAF11. There is a pseudogene located on chromosome 6. [provided by RefSeq, Jul 2008]

Primary Disease Associations & Inheritance

Intellectual developmental disorder, autosomal recessive 60MIM #617432
AR
0
Active trials
18
Pathogenic / LP
47
ClinVar variants
3
Pubs (1 yr)
1.3
Missense Z
1.08
LOEUF
Clinical SummaryTAF13
Population Constraint (gnomAD)
Low constraint (pLI 0.02) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
18 Pathogenic / Likely Pathogenic· 25 VUS of 47 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.08LOEUF
pLI 0.016
Z-score 1.41
OE 0.47 (0.231.08)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
1.26Z-score
OE missense 0.55 (0.420.73)
35 obs / 63.2 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.47 (0.231.08)
00.351.4
Missense OE0.55 (0.420.73)
00.61.4
Synonymous OE1.24
01.21.6
LoF obs/exp: 4 / 8.4Missense obs/exp: 35 / 63.2Syn Z: -0.83
DN
DN
0.7327th %ile
GOF
0.4578th %ile
LOF
0.3648th %ile

The highest-scoring mechanism for this gene is dominant-negative.

DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

47 submitted variants in ClinVar

Classification Summary

Pathogenic14
Likely Pathogenic4
VUS25
Likely Benign3
Benign1
14
Pathogenic
4
Likely Pathogenic
25
VUS
3
Likely Benign
1
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
2
12
0
14
Likely Pathogenic
1
0
3
0
4
VUS
1
6
18
0
25
Likely Benign
0
0
1
2
3
Benign
0
0
1
0
1
Total2835247

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

TAF13 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Gene2Phenotype Curations

TAF13-related intellectual disability and microcephaly

strong
ARUndeterminedAltered Gene Product Structure
Dev. Disorders
G2P ↗
missense variantinframe deletioninframe insertion

Gene2Phenotype curations · DECIPHER consortium patient cohort (public variants) · deciphergenomics.org

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Landmark / reviewRecent case evidence